Cargando…

Techniques to Study Inflammasome Activation and Inhibition by Small Molecules

Inflammasomes are immune cytosolic oligomers involved in the initiation and progression of multiple pathologies and diseases. The tight regulation of these immune sensors is necessary to control an optimal inflammatory response and recover organism homeostasis. Prolonged activation of inflammasomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angosto-Bazarra, Diego, Molina-López, Cristina, Peñín-Franch, Alejandro, Hurtado-Navarro, Laura, Pelegrín, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003184/ https://www.ncbi.nlm.nih.gov/pubmed/33803783 http://dx.doi.org/10.3390/molecules26061704

Ejemplares similares

Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity
por: García-Villalba, Julio, et al.
Publicado: (2022)

NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers
por: Hurtado-Navarro, Laura, et al.
Publicado: (2022)

Physiological and pathophysiological functions of NLRP6: pro- and anti-inflammatory roles
por: Angosto-Bazarra, Diego, et al.
Publicado: (2022)

Evolutionary analyses of the gasdermin family suggest conserved roles in infection response despite loss of pore-forming functionality
por: Angosto-Bazarra, Diego, et al.
Publicado: (2022)

Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation
por: Tapia-Abellán, Ana, et al.
Publicado: (2021)

NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
por: Hafner-Bratkovič, Iva, et al.
Publicado: (2018)

Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation
por: Lucas-Ruiz, Fernando, et al.
Publicado: (2022)

Galvanic current activates the NLRP3 inflammasome to promote Type I collagen production in tendon
por: Peñin-Franch, Alejandro, et al.
Publicado: (2022)

MCC950 closes the active conformation of NLRP3 to an inactive state
por: Tapia-Abellán, Ana, et al.
Publicado: (2019)

P2X7 receptor activation impairs antitumour activity of natural killer cells
por: Baroja‐Mazo, Alberto, et al.
Publicado: (2022)

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure
por: Malhotra, Sunny, et al.
Publicado: (2023)

ASC nanobodies to counteract the consequences of inflammasome activation
por: Adriouch, Sahil, et al.
Publicado: (2022)

P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis
por: Martínez-García, Juan José, et al.
Publicado: (2019)

Neutrophils mediate Salmonella Typhimurium clearance through the GBP4 inflammasome-dependent production of prostaglandins
por: Tyrkalska, Sylwia D., et al.
Publicado: (2016)

Emerging Role of the Inflammasome and Pyroptosis in Hypertension
por: De Miguel, Carmen, et al.
Publicado: (2021)

ASC oligomer favors caspase-1(CARD) domain recruitment after intracellular potassium efflux
por: Martín-Sánchez, Fátima, et al.
Publicado: (2023)

The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
por: de Torre-Minguela, Carlos, et al.
Publicado: (2017)

Cryptococcus neoformans Secretes Small Molecules That Inhibit IL-1β Inflammasome-Dependent Secretion
por: Bürgel, Pedro Henrique, et al.
Publicado: (2020)

Carbon monoxide releasing molecule-3 inhibits inflammasome activation: A potential therapy for spinal cord injury
por: de Rivero Vaccari, Juan Pablo
Publicado: (2019)

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
por: Seok, Jin Kyung, et al.
Publicado: (2021)

The inflammasome pathway in stable COPD and acute exacerbations
por: Faner, Rosa, et al.
Publicado: (2016)

A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
por: Zhang, CongXiao, et al.
Publicado: (2019)

Discovery and characterization of small-molecule inhibitors of NLRP3 and NLRC4 inflammasomes
por: Sebastian-Valverde, Maria, et al.
Publicado: (2021)

Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington’s disease treatment
por: Lopez-Hurtado, Alejandro, et al.
Publicado: (2019)

Lipin-2 regulates NLRP3 inflammasome by affecting P2X(7) receptor activation
por: Lordén, Gema, et al.
Publicado: (2017)

Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection
por: Amores-Iniesta, Joaquín, et al.
Publicado: (2017)

JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders
por: Ambrus-Aikelin, Geza, et al.
Publicado: (2023)

A Synthetic Small Molecule F240B Decreases NLRP3 Inflammasome Activation by Autophagy Induction
por: Wu, Chun-Hsien, et al.
Publicado: (2020)

The regulation of self-tolerance and the role of inflammasome molecules
por: Ke, Qi, et al.
Publicado: (2023)

Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation
por: Lucas-Ruiz, Fernando, et al.
Publicado: (2022)

Correction to: Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome
por: Reula, Alfonso José Tapiz i, et al.
Publicado: (2022)

Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome
por: Tapiz i Reula, Alfonso José, et al.
Publicado: (2022)

Corrigendum: A Synthetic Small Molecule F240B Decreases NLRP3 Inflammasome Activation by Autophagy Induction
por: Wu, Chun-Hsien, et al.
Publicado: (2021)

Inhibition of the NLRP3 inflammasome prevents ovarian aging
por: Navarro-Pando, José M., et al.
Publicado: (2021)

NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation
por: Habas, Agata, et al.
Publicado: (2022)

Small Molecule Inhibition of RISC Loading
por: Tan, Grace S., et al.
Publicado: (2011)

Inhibition of autotransporter biogenesis by small molecules
por: Steenhuis, Maurice, et al.
Publicado: (2019)

Small-Molecule Inhibition of Bacterial Biofilm
por: Ghosh, Anirban, et al.
Publicado: (2020)

Small Molecule Drugs That Inhibit Phagocytosis
por: Loriamini, Melika, et al.
Publicado: (2023)

Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome
por: Otani, Koji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jkvjbslci2v6clvjhjlosjujod